Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4+ T cell help
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4+ T cell help
Authors
Keywords
SARS-CoV-2, COVID-19, memory B cells, spike, CD4, T cell, IL-21, CD40L, antibody, recovered, severely ill
Journal
Cell Reports
Volume 35, Issue 13, Pages 109320
Publisher
Elsevier BV
Online
2021-06-11
DOI
10.1016/j.celrep.2021.109320
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19
- (2021) Jun Wu et al. Nature Communications
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection
- (2020) Paul Kellam et al. JOURNAL OF GENERAL VIROLOGY
- Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
- (2020) Stephen M. Kissler et al. SCIENCE
- Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
- (2020) Christoph Kreer et al. CELL
- SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
- (2020) Nina Le Bert et al. NATURE
- Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
- (2020) Jennifer A. Juno et al. NATURE MEDICINE
- Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
- (2020) F. Javier Ibarrondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome
- (2020) Daniela Weiskopf et al. Science Immunology
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- Expansion of atypical memory B cells is a prominent feature of COVID-19
- (2020) Barbara Oliviero et al. Cellular & Molecular Immunology
- Divergent SARS‐CoV‐2‐specific T and B cell responses in severe but not mild COVID‐19 patients
- (2020) Anna E. Oja et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Seasonal coronavirus protective immunity is short-lasting
- (2020) Arthur W. D. Edridge et al. NATURE MEDICINE
- A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
- (2020) Angkana T. Huang et al. Nature Communications
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
- (2020) Jeffrey Seow et al. Nature Microbiology
- Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany
- (2020) Hendrik Streeck et al. Nature Communications
- Naive B Cells with High-Avidity Germline-Encoded Antigen Receptors Produce Persistent IgM + and Transient IgG + Memory B Cells
- (2018) Kathryn A. Pape et al. IMMUNITY
- Silencing of high-affinity insulin-reactive B lymphocytes by anergy and impact of the NOD genetic background in mice
- (2018) Mia J. Smith et al. DIABETOLOGIA
- Circulating and intrahepatic antiviral B cells are defective in hepatitis B
- (2018) Alice R. Burton et al. JOURNAL OF CLINICAL INVESTIGATION
- Abnormal B cell memory subsets dominate HIV-specific responses in infected individuals
- (2014) Lela Kardava et al. JOURNAL OF CLINICAL INVESTIGATION
- Skewed B cells in chronic hepatitis C virus infection maintain their ability to respond to virus-induced activation
- (2014) B. Oliviero et al. JOURNAL OF VIRAL HEPATITIS
- SPICE: Exploration and analysis of post-cytometric complex multivariate datasets
- (2011) Mario Roederer et al. CYTOMETRY PART A
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started